Patient access to psilocybin will only be possible through a clinical trial setting, a number of phase 1 and 2 trials have been conducted and it is Albert Labs intention to deliver a hybrid approach with a strong emphasis on Real World Evidence (RWE)
Initially, our focus is on Cancer Related Distress both Cancer and Mental Health are National Agenda priorities with a currently high level of ‘Unmet Need’…
Restricted access #
This content is blocked for general public access. If you require access please fill out the form below and you'll be granted access.
By completing this form you agree to our privacy policy. You will be sent corporate updates and further details including how to invest in Albert Labs.
